{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/NGNE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T04:53:55.348Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":732,"canonical_name":"Neurogene Inc.","cik":"0001404644","uei":null,"lei":null,"duns":null,"ticker":"NGNE"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":24},"count":24,"timeline":[{"ts":"2026-08-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Neurogene Inc. — 2026-08-11","url_slug":"/sec/cik-0001404644/10-q/0001404644-26-000059","accession_number":"0001404644-26-000059","importance":45},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-08-11","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000056","accession_number":"0001404644-26-000056","importance":35},{"ts":"2026-07-07","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":4200,"price_per_share":36.134,"usd_value":151763,"security_title":"Common Stock","importance":35.1517628},{"ts":"2026-07-07","kind":"sec.filing","form_type":"4","title":"4 — Neurogene Inc. — 2026-07-07","url_slug":"/sec/cik-0001404644/4/0001543663-26-000017","accession_number":"0001543663-26-000017","importance":30},{"ts":"2026-07-06","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":600,"price_per_share":36.021,"usd_value":21613,"security_title":"Common Stock","importance":35.0216126},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":2531,"price_per_share":34.579,"usd_value":87519,"security_title":"Common Stock","importance":35.087519449},{"ts":"2026-07-02","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":1530,"price_per_share":35.227,"usd_value":53897,"security_title":"Common Stock","importance":35.05389731},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-07-02","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000050","accession_number":"0001404644-26-000050","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Neurogene Inc. — 2026-07-02","url_slug":"/sec/cik-0001404644/4/0001543663-26-000015","accession_number":"0001543663-26-000015","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"424B5","title":"424B5 — Neurogene Inc. — 2026-07-02","url_slug":"/sec/cik-0001404644/424b5/0001628280-26-046666","accession_number":"0001628280-26-046666","importance":30},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":739,"price_per_share":34.059,"usd_value":25170,"security_title":"Common Stock","importance":35.025169601},{"ts":"2026-06-30","kind":"sec.filing","form_type":"424B5","title":"424B5 — Neurogene Inc. — 2026-06-30","url_slug":"/sec/cik-0001404644/424b5/0001628280-26-046237","accession_number":"0001628280-26-046237","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-06-29","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000046","accession_number":"0001404644-26-000046","importance":35},{"ts":"2026-06-16","kind":"sec.filing","form_type":"3/A","title":"3/A — Neurogene Inc. — 2026-06-16","url_slug":"/sec/cik-0001404644/3-a/0001996804-26-000008","accession_number":"0001996804-26-000008","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4/A","title":"4/A — Neurogene Inc. — 2026-06-16","url_slug":"/sec/cik-0001404644/4-a/0001996804-26-000009","accession_number":"0001996804-26-000009","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4/A","title":"4/A — Neurogene Inc. — 2026-06-16","url_slug":"/sec/cik-0001404644/4-a/0001996804-26-000010","accession_number":"0001996804-26-000010","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4/A","title":"4/A — Neurogene Inc. — 2026-06-16","url_slug":"/sec/cik-0001404644/4-a/0001996804-26-000011","accession_number":"0001996804-26-000011","importance":30},{"ts":"2026-06-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-06-08","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000044","accession_number":"0001404644-26-000044","importance":35},{"ts":"2026-06-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-06-04","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000040","accession_number":"0001404644-26-000040","importance":35},{"ts":"2026-05-12","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Neurogene Inc. — 2026-05-12","url_slug":"/sec/cik-0001404644/10-q/0001404644-26-000037","accession_number":"0001404644-26-000037","importance":45},{"ts":"2026-05-12","kind":"sec.filing","form_type":"8-K","title":"8-K — Neurogene Inc. — 2026-05-12","url_slug":"/sec/cik-0001404644/8-k/0001404644-26-000038","accession_number":"0001404644-26-000038","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Neurogene Inc. — 2026-05-08","url_slug":"/sec/cik-0001404644/4/0001543663-26-000013","accession_number":"0001543663-26-000013","importance":30},{"ts":"2026-05-06","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":4800,"price_per_share":32.4358,"usd_value":155692,"security_title":"Common Stock","importance":35.15569184},{"ts":"2026-05-06","kind":"sec.insider.s","reporter":"Cvijic Christine Mikail","title":"President and CFO","shares":4800,"price_per_share":30.0732,"usd_value":144351,"security_title":"Common Stock","importance":35.14435136}]}